Procurement of SYB Pathology Managed Service

Description

This Contract Notice advertises a contract opportunity for the provision of a Pathology Managed Service Contract to the following five NHS Trusts working in partnership to deliver the South Yorkshire and Bassetlaw Pathology Service (SYB Pathology Service): (1) Barnsley Hospital NHS Foundation Trust (part of BRILS); (2) Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust; (3) The Rotherham NHS Foundation Trust; (4) Sheffield Children’s NHS Foundation Trust and (5) Sheffield Teaching Hospitals NHS Foundation Trust (STHFT) (the “MSC”). During the term of the MSC, it is anticipated that Chesterfied Royal Hospital NHS Foundation Trust (“Chesterfield) may become an associate member of the SYB Pathology Partnership in relation to Histopathology and therefore the MSC may be varied to enable Chesterfield to get the benefit of the SYB Pathology Service. On 1st April 2024 a single pathology service was established governed and managed by STHFT as the Host Organisation on behalf of the partnership. Over the coming years SYB Pathology will transition to the Target Operating Model which will deliver significant quality and efficiency benefits longer term.<br/> <br/>The establishment of the MSC will support transition to the target operating model and deliver significant quality and efficiency benefits for patients, clinicians, staff and wider stakeholders which includes the use of innovative and cutting-edge technologies. The MSC will cover all current and future workloads during its term and must meet all regulatory requirements and provide all integrated IT firmware, analysers, equipment, test kits, assays, reagents, chemicals, specific and general lab consumables and associated products and services to deliver the entire pathology and related hosted services across all sites and departments which form part of the SYB Pathology Service.<br/> <br/>Any resulting contract from this procurement process will be entered into by STHFT on behalf of the five organisations aforementioned and references to the “Authority” in this Contract Notice should be read as STHFT for and on behalf of the SYB Pathology partnership. Lot 1: The scope of the Services for the Managed Service includes the provision and maintenance of all pathology equipment and their associated IT, interfaces, and licences as well as the provision of all associated consumables; reagents, collection devices, test kits, quality control/calibration material essential for the delivery of the activity, as well as the transferring of existing assets and contracts and scope of services covered under this tender. In addition to this, the MSC provider will be responsible for the end-to-end management and delivery of the Supply Chain incorporating all products and the execution of a full Inventory Management System. Specialisms within scope of this procurement exercise as as follows; <br/><br/>Managed Service Requirements<br/>Pre & Post Analytics<br/>Clinical Biochemistry & Viral Serology <br/>Haematology <br/>Coagulation<br/>Blood Transfusion<br/>Blood Cultures<br/>IT, Interfacing and Data Management<br/><br/>The Authority is using the Competitive Procedure with Negotiation (CPN) in line with the Public Contract Regulations 2015 (as amended EU Exit (2020) etc.) to identify and define a solution which best addresses the Authority's requirements, as described within this suite of procurement documents.<br/><br/>The potential maximum aggregate value of the contract as advertised in the Find a Tender Service (FTS) is £500m. This is inclusive of all Phases and In Scope Services but also considers any potential modifications which may be made to this Contract throughout its life. As such, this is not a guaranteed value. <br/> <br/>However, for the purposes of this procurement, the maximum price is £12.4m, a total value of the 15-year contract is £186m. <br/><br/>Prices submitted for year 1 of the contract will be adjusted by the inflationary uplift only throughout the life of the contract. <br/><br/>Bids submitted which exceed the maximum price will be considered as unaffordable and will be rejected.<br/><br/>The deadline for submitting a response to the Selection Questionnaire is 19th June 2024 at 12noon.